Polazing Tablets (Polyaprezinc)
Polaprezinc 75mg
Tablet · Prescription medication
Daehan New Pharm Co., Ltd.
MFDS item code 202003553 · Approved 2020.05.15
This product's status changed to Approval withdrawn on 2024.09.11. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of gastric ulcers; improvement of gastric mucosal lesions in acute and chronic gastritis during acute exacerbations
This medication is effective for the treatment of gastric ulcers and is used to improve lesions such as erosion, bleeding, redness, and swelling of the gastric mucosa that occur during acute exacerbations of acute gastritis and chronic gastritis.
The usual adult dose is 75mg (1 tablet) of polaprezinc orally twice daily, after breakfast and before bedtime.
This medication may affect liver function; therefore, if symptoms of liver dysfunction or jaundice occur, the drug should be discontinued immediately and appropriate treatment should be received. This medication contains zinc, which may interfere with copper absorption, potentially leading to copper deficiency. This could cause anemia or decreased blood cell counts, especially in patients with poor nutritional status; treatment should be sought if abnormal symptoms arise. Due to the potential for allergic reactions, if symptoms such as rash, itching, or hives occur, administration should be discontinued. Gastrointestinal symptoms such as nausea, indigestion, constipation, vomiting, heartburn, and diarrhea may occur during treatment; if symptoms are severe, consultation with a physician is advised. If taken with penicillamine or levothyroxine sodium, the effectiveness of these drugs may decrease; precautions should be taken to space the administration of these medications adequately if they are to be taken together. Pregnant women or those who may become pregnant should only use this medication when the benefits of treatment outweigh the risks, as its safety has not been established. Lactating women should avoid this medication as it may be excreted in breast milk. Safety in children has not been confirmed; therefore, it is advisable not to use in pediatric patients. Elderly patients may have impaired gastrointestinal function, so dosage should be adjusted, and the patient's condition should be monitored closely. This medication should be kept out of reach of children and should not be transferred to other containers to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, preferably at room temperature between 1 to 30 degrees Celsius. Maintaining proper temperature and container conditions will help preserve the medication's effectiveness for a longer period.
White round tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Polaprezinc 75mg
Tablet · Prescription medication
Daehan New Pharm Co., Ltd.

Polaprezinc 75mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.

Polaprezinc 75mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

Polaprezinc 75mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Polaprezinc 75mg
Tablet · Prescription medication
Korea Paviz Pharmaceutical Co., Ltd.

Polaprezinc 75mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.
Polaprezinc 75mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Polaprezinc 75mg
Tablet · Prescription medication
Medix Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.